Literature DB >> 2110366

Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.

E L Madison1, E J Goldsmith, R D Gerard, M J Gething, J F Sambrook, R S Bassel-Duby.   

Abstract

Fibrinolysis is regulated in part by the interaction between tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1, a serine protease inhibitor of the serpin family). It is known from our earlier work that deletion of a loop of amino acids (residues 296-302) from the serine protease domain of t-PA suppresses the interaction between the two proteins without altering the reactivity of t-PA towards its substrate, plasminogen. To define more precisely the role of individual residues within this loop, we have used site-directed mutagenesis to replace Lys-296, Arg-298, and Arg-299 with negatively charged glutamic residues. Replacement of all three positively charged amino acids generates a variant of t-PA that associates inefficiently with PAI-1 and is highly resistant to inhibition by the serpin. Two t-PAs with point mutations (Arg-298----Glu and Arg-299----Glu) are partially resistant to inhibition by PAI-1 and associate with the serpin at intermediate rates. Other point mutations (Lys-296----Glu, His-297----Glu, and Pro-301----Gly) do not detectably affect the interaction of t-PA with PAI-1. None of these substitutions has a significant effect on the rate of catalysis by t-PA or on the affinity of the enzyme for its substrate, plasminogen. On the basis of these results, we propose a model in which positively charged residues located in a surface loop near the active site of t-PA form ionic bonds with complementary negatively charged residues C-terminal to the reactive center of PAI-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110366      PMCID: PMC53935          DOI: 10.1073/pnas.87.9.3530

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

Review 1.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.

Authors:  C M Hekman; D J Loskutoff
Journal:  J Biol Chem       Date:  1985-09-25       Impact factor: 5.157

3.  Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.

Authors:  A E Franke; D E Danley; F S Kaczmarek; S J Hawrylik; R D Gerard; S E Lee; K F Geoghegan
Journal:  Biochim Biophys Acta       Date:  1990-01-19

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Studies on the kinetics of plasminogen activation by tissue plasminogen activator.

Authors:  M Rånby
Journal:  Biochim Biophys Acta       Date:  1982-06-24

6.  Cold-sensitive regulatory mutants of simian virus 40.

Authors:  D DiMaio; D Nathans
Journal:  J Mol Biol       Date:  1980-06-15       Impact factor: 5.469

7.  A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.

Authors:  B Y Karlan; A S Clark; B A Littlefield
Journal:  Biochem Biophys Res Commun       Date:  1987-01-15       Impact factor: 3.575

8.  Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor.

Authors:  B Wiman; J Chmielewska; M Rånby
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

9.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

10.  Adaptation of plasminogen activator sequences to known protease structures.

Authors:  W Strassburger; A Wollmer; J E Pitts; I D Glover; I J Tickle; T L Blundell; G J Steffens; W A Günzler; F Otting; L Flohé
Journal:  FEBS Lett       Date:  1983-07-04       Impact factor: 4.124

View more
  25 in total

1.  alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.

Authors:  Thomas Sulikowski; Bryan A Bauer; Philip A Patston
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

2.  Short-lived protease serpin complexes: partial disruption of the rat trypsin active site.

Authors:  Lu Liu; Nicole Mushero; Lizbeth Hedstrom; Anne Gershenson
Journal:  Protein Sci       Date:  2007-11       Impact factor: 6.725

3.  Expression of a novel chimeric-truncated tPA in Pichia pastoris with improved biochemical properties.

Authors:  Amirhossein Saadatirad; Soroush Sardari; Mohammadreza Kazemali; Najmeh Zarei; Fatemeh Davami; Farzaneh Barkhordari; Ahmad Adeli; Fereidoun Mahboudi
Journal:  Mol Biotechnol       Date:  2014-12       Impact factor: 2.695

4.  Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Authors:  David T Berg; Bruce Gerlitz; Jing Shang; Tommy Smith; Paula Santa; Mark A Richardson; Ken D Kurz; Brian W Grinnell; Ken Mace; Bryan E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

5.  tPA regulates pulmonary vascular activity through NMDA receptors.

Authors:  Taher Nassar; Khalil Bdeir; Serge Yarovoi; Rami Abu Fanne; Juan-Carlos Murciano; Steven Idell; Timothy Craig Allen; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 6.  Structural basis of substrate specificity in the serine proteases.

Authors:  J J Perona; C S Craik
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

7.  Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.

Authors:  Likui Yang; Mao-fu Sun; David Gailani; Alireza R Rezaie
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

8.  Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.

Authors:  Galina Florova; Ali O Azghani; Sophia Karandashova; Chris Schaefer; Serge V Yarovoi; Paul J Declerck; Douglas B Cines; Steven Idell; Andrey A Komissarov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

9.  Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.

Authors:  Lihu Gong; Min Liu; Tu Zeng; Xiaoli Shi; Cai Yuan; Peter A Andreasen; Mingdong Huang
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

10.  Regulation of airway contractility by plasminogen activators through N-methyl-D-aspartate receptor-1.

Authors:  Taher Nassar; Serge Yarovoi; Rami Abu Fanne; Sa'ed Akkawi; Mahmud Jammal; Timothy Craig Allen; Steven Idell; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-22       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.